The current study was conducted at the Center for Diabetes and Endocrinology of the Health Directorate in Thi- Qar province, during the period from October 2013 to May 2014. The study aimed and evaluate immune status of diabetes type I patients by measuring the levels of interleukins (IL-2, IL-12) in the serum using a technique enzyme-linked immune sorbent adsorptive (ELISA),the study included a total of 72 patients with type I diabetes (37 males) and (35 females) and there aged between 1-40 years. When compared with 12 healthy control people.. The results showed a significant increase (P ≤ 0.01) in the levels of interleukins in the serum (IL-2, IL-12) in all patients with type I diabetes compared to the control group. Keywords: IL-2 , ...
OBJECTIVE — Interleukin-1 receptor antagonist (IL-1Ra), a natural inhibitor of interleukin-1, has be...
Type 2 diabetes mellitus (T2DM) is an important public health worldwide. The main underlying mechani...
Objective: To determine whether elevated levels of the inflammatory markers interleukin 6 (IL-6), in...
Background: Type 1 diabetes mellitus (T1DM), arising through a complex interaction of immune, geneti...
Type 2 diabetes mellitus (T2DM) is a multifactorial non-communicable disease that is characterized b...
The present study was carried out in the Labs of collage of education for pure science and Center fo...
The autoimmune disease T1DM (Type 1 diabetes mellitus) consider as important endocrine disorder desc...
Background: Type 1 diabetes is an organ specific autoimmune disease whose incidence is increasing wo...
Background: Diabetes Mellitus (DM) is a heterogeneous group of high blood sugar hyperglycemia and pr...
PubMedID: 12713258Type 1 diabetes mellitus (DM) develops as a result of autoimmune destruction of th...
WOS: 000184293800010PubMed ID: 12713258Type 1 diabetes mellitus (DM) develops as a result of autoimm...
During Type 1 Diabetes Mellitus (T1DM) progression, there is chronic and low-grade inflammation that...
During Type 1 Diabetes Mellitus (T1DM) progression, there is chronic and low-grade inflammation that...
Prediabetes is an increase-risk state for diabetes that is associated with an increase in blood gluc...
Insulin-dependent diabetes mellitus (IDDM) is a chronic disease characterized by T-cell-dependent au...
OBJECTIVE — Interleukin-1 receptor antagonist (IL-1Ra), a natural inhibitor of interleukin-1, has be...
Type 2 diabetes mellitus (T2DM) is an important public health worldwide. The main underlying mechani...
Objective: To determine whether elevated levels of the inflammatory markers interleukin 6 (IL-6), in...
Background: Type 1 diabetes mellitus (T1DM), arising through a complex interaction of immune, geneti...
Type 2 diabetes mellitus (T2DM) is a multifactorial non-communicable disease that is characterized b...
The present study was carried out in the Labs of collage of education for pure science and Center fo...
The autoimmune disease T1DM (Type 1 diabetes mellitus) consider as important endocrine disorder desc...
Background: Type 1 diabetes is an organ specific autoimmune disease whose incidence is increasing wo...
Background: Diabetes Mellitus (DM) is a heterogeneous group of high blood sugar hyperglycemia and pr...
PubMedID: 12713258Type 1 diabetes mellitus (DM) develops as a result of autoimmune destruction of th...
WOS: 000184293800010PubMed ID: 12713258Type 1 diabetes mellitus (DM) develops as a result of autoimm...
During Type 1 Diabetes Mellitus (T1DM) progression, there is chronic and low-grade inflammation that...
During Type 1 Diabetes Mellitus (T1DM) progression, there is chronic and low-grade inflammation that...
Prediabetes is an increase-risk state for diabetes that is associated with an increase in blood gluc...
Insulin-dependent diabetes mellitus (IDDM) is a chronic disease characterized by T-cell-dependent au...
OBJECTIVE — Interleukin-1 receptor antagonist (IL-1Ra), a natural inhibitor of interleukin-1, has be...
Type 2 diabetes mellitus (T2DM) is an important public health worldwide. The main underlying mechani...
Objective: To determine whether elevated levels of the inflammatory markers interleukin 6 (IL-6), in...